RNA

4 trials

Sponsors

Shenzhen Nanshan People's Hospital, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Qilu hospital Shandong University, The second affiliated Hospital of Guangzhou Medical University

Conditions

Cerebral vascular diseasebreast cancergliomanon-small cell lung cancer

Early Phase 1

Study for the correlation between the efficacy of navuzumab and immunity in patients with non-small cell lung cancer

Active, not recruitingChiCTR1900022077

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technologynon-small cell lung cancer

Start: 2019-04-20Updated: 2019-03-25

glioma CSF exosomal liquid biopsy marker sequencing

RecruitingChiCTR2000032547

Qilu hospital Shandong Universityglioma

Start: 2017-01-01Updated: 2020-05-04

piRNAs is a molecular marker and therapeutic target for early diagnosis of acute cerebral infarction

Active, not recruitingChiCTR2000040743

The second affiliated Hospital of Guangzhou Medical UniversityCerebral vascular disease

Start: 2020-12-30Updated: 2021-03-30

Unknown Phase

Differential analysis for macromolecular noncoding RNAs expression profiles of secretory in peripheral blood of breast cancer

RecruitingChiCTR1900020505

Shenzhen Nanshan People's Hospitalbreast cancer

Start: 2018-07-25Updated: 2019-01-14